BioCentury
ARTICLE | Clinical News

Micellular paclitaxel: Additional Phase III data

May 9, 2016 7:00 AM UTC

Additional data from an open-label, European Phase III trial in 789 patients with epithelial ovarian cancer showed that 250 mg/m 2 IV Paclical given as a 1-hour infusion plus carboplatin on day 1 of e...